FDA Inspection 1100378 — Gulf Coast Regional Blood Center at Cypress Fairbanks
The FDA completed an inspection of Gulf Coast Regional Blood Center at Cypress Fairbanks on June 11, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)